Invention Grant
- Patent Title: Biomarkers predictive of responsiveness to alpha 7 nicotinic acetylcholine receptor activator treatment
-
Application No.: US14735288Application Date: 2015-06-10
-
Publication No.: US09828642B2Publication Date: 2017-11-28
- Inventor: Dominik Feuerbach , Baltazar Gomez-Mancilla , Yunsheng He , Donald Johns , Cristina Lopez-Lopez , Kevin Hall McAllister , Nicole Pezous , Lisa Sandford , Markus Weiss
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Hoffman Warnick LLC
- Main IPC: G01N33/48
- IPC: G01N33/48 ; C12Q1/68 ; A61K45/06 ; A61K9/20 ; A61K31/444 ; A61K31/439 ; A61K9/16 ; A61K9/48
Abstract:
The invention provides methods for predicting therapeutic responsiveness of a subject suffering from cognitive impairments or dysfunctions, psychotic and/or neurodegenerative disorders to an alpha 7 nicotinic acetylcholine receptor activator treatment.
Public/Granted literature
- US20150275303A1 BIOMARKERS PREDICTIVE OF RESPONSIVENESS TO ALPHA 7 NICOTINIC ACETYLCHOLINE RECEPTOR ACTIVATOR TREATMENT Public/Granted day:2015-10-01
Information query
